Cost-effectiveness analysis of methods of diagnosis of tb infection in russian regions by use of recombinant tb allergen in children and adolescents

Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2017, Vol 2, Issue 2

Abstract

Background. Russia is among the countries with a high burden of TB. A new diagnostic method for TB has been developed, called ‘recombinant tuberculosis allergen’ or RTA (Diaskintest®), which has a similar cost and method of administration to the Mantoux test, but the principle of action, sensitivity and specificity are similar to IGRA technology. Despite the improvements of RTA, TB experts continue to use the Mantoux test. The aim of this study was to determine the most cost-effective medical technology for diagnosing tuberculosis infection in the Russian Federation, basing on calculation of ICER. Methods. The study was based on 3 models simulating the diagnosis of TB in Russia: 1-Mantoux test and further diagnostics methods (based on screening in 2008 in 1,302,490 Moscow children and adolescents); 2-Mantoux test with subsequent use of RTA in case of a positive Mantoux test, combined with further diagnostics methods (based on screening in 2013 in 1,420,100 Moscow children and adolescents); 3-RTA alone and further diagnostics methods (data based on screening conducted in 2015 in 108,729 Penza region children and adolescents 8-17 y.o.). Results. Method effectiveness (percentage of active TB infection among screened individuals), was 0.006%, 0.012% and 0.019% for models 1, 2 and 3, respectively. Cost-effectiveness ratios were 41861.67, 18401.67 and 10512.12 for models 1, 2 and 3, respectively. Conclusions. RTA is the most cost-effective tuberculosis screening method in children and adolescents, superior to both the stand-alone Mantoux test or the Mantoux test followed by RTA

Authors and Affiliations

Malwina Hołownia, Ilya Solodun, Ekaterina Bashlakova, Tatiana Ermolaeva, Maria Davydovskaya, Evgeniy Evdoshenko

Keywords

Related Articles

Optimization of approaches to the treatment of metastatic colorectal cancer wild-type gene KRAS

The results of the literature review of drug use for the treatment of metastatic colorectal cancer (mCRC) are presented. Analysis of the data showed that cetuximab (Erbitux) and panitumumab (Vectibix) are effective drugs...

Assessment of thrombocytopenia symptoms using vignettes. Preliminary report on the development and implementation of a new instrument

Objective: Our aim was to create a vignette enabling the assessment of the impact of thrombocytopenia symptoms on patients’ quality of life. Methods: The vignettes which we created are focused on thrombocytopenia sym...

Telemedicine - a miracle cure for everything?

Background: Telemedicine is an interesting area of modern treatment. It enables contact between patients and doctors at long distance. In this paper, we present the latest studies, conducted among Polish doctors about th...

The access to an ophthalmic treatment in Poland on the example of the ocular complications in the course of diabetes mellitus

Background Diabetic Retinopathy (DR) is the severe disease, that develops as a result of diabetes complication. All diabetic patients are at risk of DR development and the National Health Fund (NHF) estimates that ther...

The combination of angiotensin converting enzyme inhibitors, diuretics and non-steroidal anti-inflammatory drugs in the routine community pharmacy settings in Poland: The unrecognized problem of ‘Triple Whammy’. A pilot analysis.

Background: ‘Triple Whammy’ defined as a combination of angiotensin converting enzyme inhibitors/angiotensin receptor antagonist, diuretics and non-steroidal anti-inflammatory drugs remains an important clinical problem,...

Download PDF file
  • EP ID EP326199
  • DOI 10.7365/JHPOR.2017.2.5
  • Views 78
  • Downloads 0

How To Cite

Malwina Hołownia, Ilya Solodun, Ekaterina Bashlakova, Tatiana Ermolaeva, Maria Davydovskaya, Evgeniy Evdoshenko (2017). Cost-effectiveness analysis of methods of diagnosis of tb infection in russian regions by use of recombinant tb allergen in children and adolescents. JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH, 2(2), 40-45. https://europub.co.uk./articles/-A-326199